Moody's: Yestar's expectation of improved profit for 2017 supports its Ba3 rating
For the full text of this story please click the following link: http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_380210&WT.mc_id=AM~UmV1dGVyc05ld3MyX1NCX0NWX1JhdGluZ19OZXdzX0FsbA==~20180302_PR_380210
Recent news on Yestar Healthcare Holdings
See all newsBrief: Yestar Healthcare Says Guangzhou Shengshiyuan Trading Shareholders Passed Resolution To Dissolve
Brief: Yestar Healthcare Expects FY2025 Net Loss Of Not Less Than RMB65 Million
Brief: Yestar Healthcare Says Exploring And Proposes To Invest In Advanced Materials Industry
Brief: Yestar Healthcare Considering JV With Genetron Health In Singapore, Indonesia & Malaysia
Brief: Yestar Healthcare Says Wang Chunlai Appointed As Executive Director